Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

86%

6 of 7 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05084729Completed

CONFIDENCE Registry

Role: lead

NCT05337280Not ApplicableCompleted

OA for Breast Cancer NAC Response

Role: lead

NCT05022602Not ApplicableCompleted

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen 2 Imagio System

Role: lead

NCT01943916Not ApplicableCompleted

The PIONEER-01 Study of the Imagio Breast Imaging System

Role: lead

NCT03032198Not ApplicableTerminated

"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"

Role: lead

NCT03708393Not ApplicableCompleted

Imagio Feasibility Multi-Reader, Multi-Case Study

Role: lead

NCT04030104Not ApplicableCompleted

Optoacoustic Images Versus Imagio® Ultrasound

Role: lead

NCT03845907Not ApplicableSuspended

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications

Role: lead

NCT02364388Not ApplicableCompleted

IMAging With Opto-acoustics to downgradE BI-RADS claSsificaTion Relative tO Other Diagnostic Methodologies (MAESTRO)

Role: lead

All 9 trials loaded